Lenvatinib and pembrolizumab in patients with metastatic papillary renal cell carcinoma: A phase 2 pilot study.

被引：0
|
作者：
Tsimafeyeu, Ilya [1 ]
Sultanbaev Sr, Alexander [2 ]
Vilkov, Sergey
机构：
[1] Republican Clin Oncol Dispensary, Ufa, Russia
[2] Hadassah Med, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 23_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.23_suppl.109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
109
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
    Chung-Han Lee
    Robert J. Motzer
    Hilary Glen
    M. D. Michaelson
    James Larkin
    Yukinori Minoshima
    Michio Kanekiyo
    Hiroki Ikezawa
    Pallavi Sachdev
    Corina E. Dutcus
    Yasuhiro Funahashi
    Martin H. Voss
    British Journal of Cancer, 2021, 124 : 237 - 246
  • [42] Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
    Motzer, Robert J.
    Hutson, Thomas E.
    Glen, Hilary
    Michaelson, M. Dror
    Molina, Ana
    Eisen, Timothy
    Jassem, Jacek
    Zolnierek, Jakub
    Pablo Maroto, Jose
    Mellado, Begona
    Melichar, Bohuslav
    Tomasek, Jiri
    Kremer, Alton
    Kim, Han-Joo
    Wood, Karen
    Dutcus, Corina
    Larkin, James
    LANCET ONCOLOGY, 2015, 16 (15): : 1473 - 1482
  • [43] Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
    Lee, Chung-Han
    Motzer, Robert J.
    Glen, Hilary
    Michaelson, M. D.
    Larkin, James
    Minoshima, Yukinori
    Kanekiyo, Michio
    Ikezawa, Hiroki
    Sachdev, Pallavi
    Dutcus, Corina E.
    Funahashi, Yasuhiro
    Voss, Martin H.
    BRITISH JOURNAL OF CANCER, 2021, 124 (01) : 237 - 246
  • [44] Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
    Matthew T. Campbell
    Surena F. Matin
    Alda L. Tam
    Rahul A. Sheth
    Kamran Ahrar
    Rebecca S. Tidwell
    Priya Rao
    Jose A. Karam
    Christopher G. Wood
    Nizar M. Tannir
    Eric Jonasch
    Jianjun Gao
    Amado J. Zurita
    Amishi Y. Shah
    Sonali Jindal
    Fei Duan
    Sreyashi Basu
    Hong Chen
    Alexsandra B. Espejo
    James P. Allison
    Shalini S. Yadav
    Padmanee Sharma
    Nature Communications, 12
  • [45] Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
    Campbell, Matthew T.
    Matin, Surena F.
    Tam, Alda L.
    Sheth, Rahul A.
    Ahrar, Kamran
    Tidwell, Rebecca S.
    Rao, Priya
    Karam, Jose A.
    Wood, Christopher G.
    Tannir, Nizar M.
    Jonasch, Eric
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Y.
    Jindal, Sonali
    Duan, Fei
    Basu, Sreyashi
    Chen, Hong
    Espejo, Alexsandra B.
    Allison, James P.
    Yadav, Shalini S.
    Sharma, Padmanee
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [46] Pembrolizumab plus lenvatinib vs nivolumab plus cabozantinib in patients with metastatic renal cell carcinoma: A matching adjusted indirect comparison (MAIC).
    Rane, Pratik
    Walton, Laura
    Schmidinger, Manuela
    Peer, Avivit
    Mt-Isa, Shahrul
    Burgents, Joseph E.
    Sundaram, Murali
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 399 - 399
  • [47] Phase II study of vinflunine in patients with metastatic renal cell carcinoma
    D. Goldstein
    S. P. Ackland
    D. R. Bell
    I. N. Olver
    I. D. Davis
    M. A. Rosenthal
    G. C. Toner
    M. C. Pinel
    M. Byrne
    Investigational New Drugs, 2006, 24 : 429 - 434
  • [48] Phase II study of lenalidomide in patients with metastatic renal cell carcinoma
    Choueiri, Toni K.
    Dreicer, Robert
    Rini, Brian I.
    Elson, Paul
    Garcia, Jorge A.
    Thakkar, Snehal G.
    Baz, Rachid C.
    Mekhail, Tarek M.
    Jinks, Holly A.
    Bukowski, Ronald M.
    CANCER, 2006, 107 (11) : 2609 - 2616
  • [49] Phase II study of vinflunine in patients with metastatic renal cell carcinoma
    Goldstein, D.
    Ackland, S. P.
    Bell, D. R.
    Olver, I. N.
    Davis, I. D.
    Rosenthal, M. A.
    Toner, G. C.
    Pinel, M. C.
    Byrne, M.
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) : 429 - 434
  • [50] Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.
    Giaccone, Giuseppe
    Thompson, Jillian
    McGuire, Colleen
    Manning, Maria
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Subramaniam, Deepa Suresh
    Liu, Stephen V.
    Gibney, Geoffrey Thomas
    Kim, Chul
    McCutcheon, Justine N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345